Computational Strategies For Exploring Amino Acids And Peptides As Inhibitors Of Advanced Glycation Endproducts
Our bodies naturally produce harmful molecules called Advanced Glycation Endproducts, or AGEs, which accumulate over time and are linked to aging and serious health issues like diabetes, heart disease, and neurodegenerative disorders. Preventing the formation of these AGEs is a crucial strategy for developing new treatments.
Scientists are now turning to powerful computational tools to explore the potential of amino acids and peptides—the fundamental building blocks of proteins—as inhibitors. Imagine using sophisticated computer simulations to “virtually test” how different amino acids and peptides interact with the molecules that lead to AGE formation. Techniques like molecular docking and molecular dynamics allow researchers to predict how strongly these potential inhibitors bind and how stable these interactions are.
Beyond simply visualizing interactions, other computational methods, such as those based on density functional theory, help understand the chemical reactivity of these compounds. Additionally, machine learning and quantitative structure-activity relationship (QSAR) models enable the rapid screening of a vast number of candidates, identifying the most promising ones much faster than traditional laboratory experiments. This integrated computational approach is accelerating the rational design of new, effective therapies to combat the diseases associated with AGEs, paving the way for more efficient drug discovery.
Source: link to paper